Profile data is unavailable for this security.
About the company
Enzymatica publ AB is a Sweden-based company engaged in biotechnology. It researches, develops and registers enzyme-based health and wellbeing products. The Company uses a patented enzyme, Penzyme, a cold-adapted trypsin from deep sea cod. The enzyme is active at about 37 Celsius degree and decomposes disease-related proteins, counteracting viral and bacterial infections and supporting healing processes. The Company conducts clinical studies of ColdZyme Munspray, a cold medicine. It operates such subsidiaries, as Enzymatica Care AB, Zymetech ehf, among others. Main shareholders of Enzymatica AB are Humea AB, Medi AB, and Nordic Consulting Group AB, among others. In November 2013, the Company established another subsidiary in the United States, Enzymatica North America Inc., responsible for future production and sale of veterinary products in the United States and Canada.
- Revenue in SEK (TTM)44.95m
- Net income in SEK-55.95m
- Incorporated2007
- Employees16.00
- LocationEnzymatica AB (publ)Ideon Science Park, Scheelevagen 19LUND 223 70SwedenSWE
- Phone+46 462863100
- Websitehttps://www.enzymatica.se/
